RenalGuard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation

Gabriella Visconti, Amelia Focaccio, Michael Donahue, Bruno Golia, Antonio Marzano, Elvira Donnarumma, Bruno Ricciardelli, Lucio Selvetella, Luigi Marino, Carlo Briguori

Research output: Contribution to journalArticle

Abstract

Aims: We aimed to assess whether the RenalGuard™ System is effective in preventing acute kidney injury (AKI) following transcatheter aortic valve implantation (TAVI). Methods and results: Forty-eight consecutive patients with chronic kidney disease (CKD) scheduled for TAVI were assigned to: 1) hydration with sodium bicarbonate solution (Control group), or 2) hydration with RenalGuard Therapy® (RenalGuard group). Hypotension was defined as periprocedural mean blood pressure

Original languageEnglish
Pages (from-to)e1658-e1661
JournalEuroIntervention
Volume11
Issue number14
DOIs
Publication statusPublished - Apr 1 2016

Keywords

  • Aortic valve stenosis
  • Complication
  • Kidney
  • Prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'RenalGuard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation'. Together they form a unique fingerprint.

  • Cite this

    Visconti, G., Focaccio, A., Donahue, M., Golia, B., Marzano, A., Donnarumma, E., Ricciardelli, B., Selvetella, L., Marino, L., & Briguori, C. (2016). RenalGuard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation. EuroIntervention, 11(14), e1658-e1661. https://doi.org/10.4244/EIJV11I14A317